Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
Immunotherapy based on checkpoint inhibitors is providing substantial clinical benefit, but only to a minority of cancer patients. The current priority is to understand why the majority of patients fail to respond. Besides T-cell dysfunction, T-cell apoptosis was reported in several recent studies a...
Главные авторы: | Zhu, J, Petit, P, Van Den Eynde, B |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Springer Berlin Heidelberg
2018
|
Схожие документы
-
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
по: Zhu, J, и др.
Опубликовано: (2017) -
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
по: Jingjing Zhu, и др.
Опубликовано: (2017-11-01) -
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
по: Jeroen F. Vermeulen, и др.
Опубликовано: (2018-03-01) -
Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy
по: Ioana Plesca, и др.
Опубликовано: (2020-03-01) -
Infiltrating T lymphocytes and tumor microenvironment within cholangiocarcinoma: immune heterogeneity, intercellular communication, immune checkpoints
по: Yunyan Dai, и др.
Опубликовано: (2025-01-01)